Bio-Rad and 10X Genomics end patent fight with new licensing deal
29-07-2021
10x Genomics strikes back in Bio-Rad saga with USITC ban
13-02-2020
rafapress / Shutterstock.com
Bio-Rad has asked the US Court of Appeals for the Federal Circuit to review its prior decisions that affirmed Bio-Rad had infringed three 10X Genomics patents.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Bio-Rad, 10X Genomics, Federal Circuit, ITC, Patents, DNA sequencing, Inventorship
